Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial (TRIDENT) Cognitive Sub-Study

Clinical trial NCT03785067 · TERMINATED

Trial details

NCT number: NCT03785067
Sponsor: The George Institute
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Cognitive Decline Intracerebral Hemorrhage Dementia, Vascular Cerebral Small Vessel Diseases Hypertension Stroke Hemorrhagic

Start date: 2020-02-27
Primary completion: 2021-02-03
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.